Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: J Magn Reson Imaging. 2011 Apr;33(4):808–816. doi: 10.1002/jmri.22517

Figure 1.

Figure 1

Non-enhancing Grade 3 astrocytoma (A) contrast-enhanced T1-weighted MRI showing PRESS box (black) where MRS data was acquired and biopsy location (red). (B) 3D-MR spectra and (C) apparent diffusion coefficient image map were that were used to select the biopsy location prior to surgery. Post-surgical (F) HRMAS MR spectrum, immunohistochemical (D) Ki-67 and (E) VEGF labeling of biopsied tissue sample.